Where is Pando located?

Pando is headquartered in Watertown, United States.

Who is the current CEO of Pando?

Will Cao of Pando. They have also founded 1 company.

How many employees does Pando have?

As of Apr 30, 2026, the latest employee count at Pando is 6.

Is Pando a funded company?

Pando is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round.

When was the latest funding round of Pando?

Pando's latest funding was a $***** Seed round, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $522M in funding in 2026 to date.

Where does Pando rank among its competitors?

Pando ranks 314th amongst 2660 active competitors, of which 289 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Evotec, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of Pando?

Pando's top competitors include Ginkgo Bioworks, Evotec and Syngenta. Among them, Evotec secured the most recent funding round in January, 2026.

Pando - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of AI-designed enzymes for pharmaceutical manufacturing and diagnostics applications. The company offers engineered enzymes for molecular biology applications. It utilizes its technology to deliver enzyme solutions.

Website: www.pando.bio/
Email ID: *****@pando.bio

Key Metrics

Founded Year

2023

Location

Watertown, United States

Stage

Seed

Total Funding

$50K in 1 round

Latest Funding Round

Seed, $*****

Investors

Y Combinator

Ranked

314^th among 2660 active competitors

Employee Count

6 as on Apr 30, 2026

Similar Companies

Ginkgo Bioworks & 5009 more

View Pando's full profile

Pando has raised a total funding of $50K over 1 round. Its latest funding round was a Seed round. 1 investor participated in its latest round. Pando has 1 institutional investor.

View details of Pando's funding rounds and investors

The founders of Pando are Yang Wang and Will Cao. Will Cao is the CEO of Pando.

Here are the details of Pando's key team members:

Yang Wang: Co-Founder of Pando.
Contact Info: 1 email address
Will Cao: Co-Founder & CEO of Pando.

View details of Pando's Founder profiles and Board Members

Pando's employee count trend

Pando has 6 employees as of Apr 26. Here is Pando's employee count trend over the years:

Uncover Pando's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pando include Ginkgo Bioworks, Evotec and Syngenta. Here is the list of Top 10 competitors of Pando, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Evotec 1993, Hamburg (Germany), Public	AI-driven life science company accelerating drug discovery and development	$25.1M	Military Health, Eiffel Investment Group ... & 22 others	76/100
3rd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Europa, Analah Ventures	75/100
4th	Goodfire 2024, San Francisco (United States), Series B	Interpretability tooling for generative AI models	$209M	B Capital, Menlo Ventures & 11 others	71/100
5th	Fireworks 2022, Redwood City (United States), Series C	Generative AI platform as a service for accelerating product innovation and disruption	$307M	Sequoia Capital, Index Ventures & 12 others	71/100
6th	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	71/100
7th	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
8th	Insitro 2018, San Francisco (United States), Series C	Developer of machine learning platform for drug discovery and development	$643M	Andreessen Horowitz, Foresite Capital & 18 others	70/100
9th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Dentsu Ventures & 39 others	70/100
10th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	OSTI, FirstMark & 12 others	68/100
314th	Pando 2023, Watertown (United States), Seed	Developer of AI-designed enzymes for pharmaceutical manufacturing and diagnostics applications	$50K	Y Combinator	31/100